Table 2.
Body composition
| Baseline | Δ Week 16 | p value* | |||
|---|---|---|---|---|---|
| Gpp | Placebo | Gpp | Placebo | ||
| Body mass (kg) | 88.1 (16.7) | 89.2 (13.8) | −0.96 | 0.31 | 0.02* |
| Lean mass (kg) | 54.9 (14.5) | 55.5 (12.4) | 0.12 | 0.33 | 0.480 |
| Fat mass (kg) | 30.5 (6.9) | 31.2 (7.5) | −0.98 | −0.04 | 0.048* |
| Lean mass (%) | 61.8 (7.0) | 61.8 (7.6) | 0.73 | 0.13 | 0.07 |
| Fat mass (%) | 35.1 (7.2) | 35.3 (7.8) | −1.26 | −0.10 | 0.09 |
| Fat mass trunk (kg) | 15.7 (3.9) | 15.8 (4.6) | −0.67 | −0.12 | 0.08 |
| Body mass index (kg m–2) | 29.6 (3.3) | 30.4 (3.1) | −0.24 | 0.14 | 0.049* |
| Android mass (kg) | 2.8 (0.9) | 2.9 (1.0) | −0.15 | −0.03 | 0.07 |
| Gynoid mass (kg) | 5.1 (1.5) | 5.1 (1.7) | −0.16 | 0.05 | 0.03* |
| Android/gynoid ratio | 1.1 (0.2) | 1.1 (0.2) | −0.026 | −0.008 | 0.08 |
| Visceral fat (g)a | 854.4 (590.0) | 818.7 (597) | −36.7 | 7.19 | 0.22 |
| Waist circumference (cm) | 100.4 (11.6) | 101.4 (10.1) | −0.46 | −0.39 | 0.90 |
| Hip circumference (cm) | 113.3 (7.1) | 113.0 (7.7) | −0.79 | −0.48 | 0.30 |
Note: Dual‐energy X‐ray absorptiometry data collected for 52 participants from both groups.
Abbreviations: Gpp, Gynostemma pentaphyllum; Δ, change from baseline.
a
These variables have a log‐normal distribution and were logN transformed for t‐test analysis.
*
p values for likelihood of difference between the Gpp and placebo groups.